NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 992.00
-15.00 (-1.49%)
At close: Jun 5, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 24.69 billion as of June 8, 2026. Its market cap has decreased by -32.62% in one year.
Market Cap
24.69B
Enterprise Value
50.51B
Revenue
31.20B
Ranking
n/a
PE Ratio
n/a
Stock Price
992.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 24.69B, a decrease of -92.12%. That is a compound annual growth rate of -37.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 24.69B | -32.45% |
| Dec 30, 2025 | 36.56B | 12.79% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.23% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADBiotech | 49.20B |
| HLB Pep | 46.51B |
| J2KBIO | 45.67B |
| Parataxis Korea | 44.13B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 33.20B |
| MOA Life Plus | 28.46B |